Related Experiment Videos
Multiple myeloma complicated with pseudomonas endocarditis
Juliana Todaro1, Patrícia Weinschenker Bollmann, Amit Nussbacher
1Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Abstract:
Patients diagnosed with multiple myeloma are more susceptible to infections which are the major causes of morbidity and mortality associated to this disease. The main infectious agents involved are Gram-positive bacteria. However, after chemotherapy an increase in the incidence of Gram-negative strains is observed. These bacteria are also responsible for most cases of urinary tract infections. Here is reported a rare case in a 73-year-old man with multiple myeloma who developed endocarditis due to pseudomonas.
Insights
Multiple myeloma patients face infection risks, primarily from Gram-positive bacteria. This case highlights a rare instance of Gram-negative Pseudomonas endocarditis in a myeloma patient post-chemotherapy.
Area of Science:
- Infectious Diseases
- Hematology
- Oncology
Background:
- Multiple myeloma (MM) patients exhibit increased susceptibility to infections, a leading cause of morbidity and mortality.
- Gram-positive bacteria are typically the primary pathogens, but chemotherapy can alter this, increasing Gram-negative infections.
- Urinary tract infections are common in MM patients, often caused by Gram-negative bacteria.
Observation:
- A rare case of endocarditis in a 73-year-old male patient with multiple myeloma is presented.
- The patient developed endocarditis caused by Pseudomonas, a Gram-negative bacterium.
- This observation is noteworthy given the typical infectious profiles in multiple myeloma.
Findings:
- The case demonstrates a rare complication of Pseudomonas endocarditis in a multiple myeloma patient.
- This underscores the potential shift towards Gram-negative infections, including rare sites like the heart valves, post-chemotherapy.
- Pseudomonas species can cause severe invasive infections in immunocompromised hosts.
Implications:
- Highlights the need for vigilance regarding Gram-negative infections in multiple myeloma patients, especially after chemotherapy.
- Suggests that diagnostic and therapeutic strategies may need to consider a broader spectrum of pathogens.
- Emphasizes the importance of early detection and management of rare infectious complications in immunocompromised individuals.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Endocarditis I: Introduction
Atypical Pneumonia
Pneumonia III: Complications and Assessment